IndieBio -Designing Science

Jamie Wheal , Executive Director of The Flow Genome Project & Co-Author of "Stealing Fire" featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.

IndieBio is a member of SOSV a $700M global fund focused on lasting impact.

Follow on www.twitter.com/indbio

Rick Doblin, Founder and Executive Director of Multidisciplinary Association for Psychedelic Studies (MAPS) featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.

IndieBio is a member of SOSV a $700M global fund focused on lasting impact.

Follow on www.twitter.com/indbio

Melanie Matheu, C.E.O. & Founder of Prellis Biologics featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.

IndieBio is a member of SOSV a $700M global fund focused on lasting impact.

Follow on www.twitter.com/indbio

Maria Soloveychik, co-founder and CEO of SyntheX featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.

IndieBio is a member of SOSV a $700M global fund focused on lasting impact.

Follow on www.twitter.com/indbio

Hyunjun Park, co-founder and CEO of Catalog featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.

IndieBio is a member of SOSV a $700M global fund focused on lasting impact.

Follow on www.twitter.com/indbio

Darrin Crisitello, Vice President, Global Sales, Marketing, and Operations at Color Genomics & IndieBio Adjunct Partner featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.

IndieBio is a member of SOSV a $700M global fund focused on lasting impact.

Follow on www.twitter.com/indbio

Po Bronson, Futurist & 7x NY Times Best Selling Author featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $1B.

IndieBio is a member of SOSV a $650M global fund focused on lasting impact.

Follow on www.twitter.com/indbio

Dariush Mozaffarian, Dean of Tufts Friedman School of Nutrition Science and Policy, featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.

IndieBio is a member of SOSV a $700M global fund focused on lasting impact.

Follow on www.twitter.com/indbio

Joon Yun, President and Managing Partner of Palo Alto Investors, Founder of the Palo Alto Prize for Longevity, featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $1B.

IndieBio is a member of SOSV a $650M global fund focused on lasting impact.

Follow on www.twitter.com/indbio

Ursheet Parikh, Partner at Mayfield Fund, entrepreneur and investor featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.

IndieBio is a member of SOSV a $700M global fund focused on lasting impact.

Follow on www.twitter.com/indbio